- Home
- RMR vs FHTX Comparison
RMR vs FHTX Comparison
Compare RMR & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMR
- FHTX
- Stock Information
- Founded
- RMR 1986
- FHTX 2015
- Country
- RMR United States
- FHTX United States
- Employees
- RMR N/A
- FHTX N/A
- Industry
- RMR Professional Services
- FHTX Medicinal Chemicals and Botanical Products
- Sector
- RMR Consumer Discretionary
- FHTX Health Care
- Exchange
- RMR Nasdaq
- FHTX Nasdaq
- Market Cap
- RMR 255.2M
- FHTX 278.1M
- IPO Year
- RMR N/A
- FHTX 2020
- Fundamental
- Price
- RMR $14.49
- FHTX $4.23
- Analyst Decision
- RMR
- FHTX Strong Buy
- Analyst Count
- RMR 0
- FHTX 5
- Target Price
- RMR N/A
- FHTX $11.80
- AVG Volume (30 Days)
- RMR 133.8K
- FHTX 270.7K
- Earning Date
- RMR 11-12-2025
- FHTX 10-31-2025
- Dividend Yield
- RMR 12.42%
- FHTX N/A
- EPS Growth
- RMR N/A
- FHTX N/A
- EPS
- RMR 1.12
- FHTX N/A
- Revenue
- RMR $194,993,000.00
- FHTX $24,173,000.00
- Revenue This Year
- RMR $323.25
- FHTX $42.43
- Revenue Next Year
- RMR N/A
- FHTX $14.77
- P/E Ratio
- RMR $12.90
- FHTX N/A
- Revenue Growth
- RMR 1.73
- FHTX N/A
- 52 Week Low
- RMR $13.48
- FHTX $2.95
- 52 Week High
- RMR $24.84
- FHTX $9.70
- Technical
- Relative Strength Index (RSI)
- RMR 33.83
- FHTX 45.28
- Support Level
- RMR $14.27
- FHTX $3.85
- Resistance Level
- RMR $15.34
- FHTX $4.69
- Average True Range (ATR)
- RMR 0.48
- FHTX 0.33
- MACD
- RMR 0.01
- FHTX 0.04
- Stochastic Oscillator
- RMR 12.72
- FHTX 55.77
About RMR The RMR Group Inc.
The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.